Skip to content
Important Health
What Actually Matters
  • Health Policy
  • Outbreak Watch
  • Public Health
  • Risk Factors
  • Screening Guidelines

Author: Winda Azhari

Sheba Medical Center Partners with OpenAI to Advance AI-Powered Healthcare

Sheba Medical Center Partners with OpenAI to Advance AI-Powered Healthcare

15/10/2026 • 2 days ago
Sheba Medical Center partners with OpenAI to advance AI-powered healthcare, integrating ChatGPT for clinicians across its network.
Talus Bio Skips Protein Folding for 5,000-Fold Drug Speed

Talus Bio Skips Protein Folding for 5,000-Fold Drug Speed

14/10/2026 • 3 days ago
Drug discovery speed improves 5,000-fold as Talus Bio skips protein folding to target previously undruggable proteins in their innovative screening...
Expanded Pharma Tariffs Target Smaller Drugmakers Over R&D Fears

Expanded Pharma Tariffs Target Smaller Drugmakers Over R&D Fears

13/10/2026 • 4 days ago
Expanded pharma tariffs now target mid-sized and smaller drugmakers, raising R&D costs and industry concerns over innovation and pricing strategies.
AI agents help manage data surge in trials

AI agents help manage data surge in trials

10/10/2026 • 7 days ago
Phase-3 clinical trials are generating unprecedented data volumes, a trend that fuels the vision of an autonomous clinical trial while...
Moving to Wealthier Areas Cuts Diabetes Risk

Moving to Wealthier Areas Cuts Diabetes Risk

03/10/2026 • 2 weeks ago
Research presented at the European Association for the Study of Diabetes meeting in Milan indicates that moving from a high-poverty...
South Goa Hospital Moves College Amid Bed Crunch

South Goa Hospital Moves College Amid Bed Crunch

02/10/2026 • 2 weeks ago
South Goa District Hospital is considering a temporary relocation of its nursing college to address critical space shortages for patients....
Glenmark launches triple-action hypertension pill in India

Glenmark launches triple-action hypertension pill in India

29/09/2026 • 3 weeks ago
Glenmark Pharmaceuticals has introduced Telma AM Biso , a fixed-dose combination tablet containing telmisartan, amlodipine, and bisoprolol for treating.
UofL Health Achieves $1.5M Monthly Anesthesia Savings

UofL Health Achieves $1.5M Monthly Anesthesia Savings

19/09/2026 • 4 weeks ago
UofL Health achieved $1.5M monthly anesthesia savings by standardizing operations across 59 operating rooms and implementing a single data source...
Health data utilities advance public health, education coordination

Health data utilities advance public health, education coordination

16/09/2026 • 1 month ago
Health data utilities (HDUs) are becoming essential infrastructure for public health, education, and rural care coordination at Civitas Networks.
UNC Study Tests Doulas and Alerts to Improve Black Maternal

UNC Study Tests Doulas and Alerts to Improve Black Maternal

15/09/2026 • 1 month ago
UNC researchers test doulas and alerts to improve Black maternal health outcomes in a major $10 million study funded by...
12»

Latest Post

  • PharmSci conference adds new research tracks
  • Sheba Medical Center Partners with OpenAI to Advance AI-Powered Healthcare
  • Talus Bio Skips Protein Folding for 5,000-Fold Drug Speed
  • Expanded Pharma Tariffs Target Smaller Drugmakers Over R&D Fears
  • FDA finalizes guidance on written responses and meeting types
  • AbbVie Reports High Cure Rate for Acute Hepatitis C
  • AI agents help manage data surge in trials

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Sitemap
  • Terms of Service

Social Media

Facebook Facebook
YouTube YouTube
Twitter Twitter / X
Instagram Instagram
Important Health

What Actually Matters

Categories

  • Risk Factors
  • Screening Guidelines
  • Public Health
  • Health Policy
  • Outbreak Watch

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Terms of Service
  • Sitemap

Latest Post

  • PharmSci conference adds new research tracks
  • Sheba Medical Center Partners with OpenAI to Advance AI-Powered Healthcare
  • Talus Bio Skips Protein Folding for 5,000-Fold Drug Speed
  • Expanded Pharma Tariffs Target Smaller Drugmakers Over R&D Fears
  • FDA finalizes guidance on written responses and meeting types
© 2026 Important Health. All rights reserved.